Literature DB >> 34670892

Rippling Muscle Disease with Irregular Toe Jerks and Anti-acetylcholine Receptor Antibodies: Remission after Extended Thymectomy.

Nanaka Yamaguchi1,2, Shunichi Matsuda1, Jun Matsumoto3, Yoshikazu Ugawa4, Jun Shimizu2,5, Tatsushi Toda2, Masahiro Sonoo6, Toshihiro Yoshizawa1.   

Abstract

We herein report a 63-year-old rippling muscle disease (RMD) patient who presented with painless stiffness, muscle hypertrophy and muscle contractions elicited by mechanical stimulation. He also showed irregular toe jerks and a slightly elevated level of anti-acetylcholine receptor antibody (AChR-Ab). Since he had a mediastinal mass mimicking thymoma, which was later revealed to be a bronchial cyst, he underwent extended thymectomy. The irregular toe jerks disappeared within a week after the operation. The other muscle symptoms completely remitted 27 months after the onset. This is the first report of a sporadic case of RMD with irregular toe jerks that resolved after extended thymectomy.

Entities:  

Keywords:  anti-acetylcholine receptor antibody; caveolin-3; muscle biopsy; muscle jerk; thymectomy

Mesh:

Substances:

Year:  2021        PMID: 34670892      PMCID: PMC9152870          DOI: 10.2169/internalmedicine.8146-21

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.282


Introduction

Rippling muscle disease (RMD) is a rare disorder characterized by muscle stiffness, muscle hypertrophy and rippling muscle induced by stretching or percussion that occurs in both familial and sporadic forms (1,2). Most cases with non-familial RMD cases have been reported to be associated with autoimmune diseases or cancers and responded to immunosuppressive therapy (2-9). However, sporadic RMD cases initially unassociated with autoimmune or malignant disorders rarely undergo treatments and sometimes later develop myasthenia gravis (MG) (4,10,11). We herein report a man with sporadic RMD without coexisting autoimmune disorders or malignancy who uniquely showed irregular toe jerks. Since he had a slightly elevated serum anti-acetylcholine receptor antibody (AChR-Ab) level and a mediastinal mass mimicking thymoma, he underwent extended thymectomy. His frequent irregular toe jerks disappeared within a week after the operation, and his muscle rippling and stiffness gradually improved over two years after the operation without further therapies. He did not show any signs and symptoms of autoimmune disorders, including MG, at 39 months after the operation. Our case may illustrate a wide spectrum of neurological manifestations associated with sporadic RMD.

Case Report

A 63-year-old man was admitted to our outpatient clinic with muscle stiffness after exercise for 8 months. He first noticed muscle stiffness in his lower leg muscles after exercise, which spread to his arms and pectoralis muscles eight months later. Since a blood test revealed an elevated level of creatine kinase (CK; 883 U/L) 4 months after the onset of the stiffness, he stopped atorvastatin used for 14 months. Despite cessation of the atorvastatin, he felt difficulty moving his legs in daily activities due to painless stiffness and was admitted to our hospital. He had no easy fatigability. He had proximal limb muscle hypertrophy, a wave of muscle contractions and focal mounding elicited by mechanical stimulation on the biceps brachii, rectus femori, and soleus muscle. A neurological examination revealed no other abnormal findings. Needle electromyography (nEMG) showed that the muscular contraction and focal mounding were electrically silent, suggesting that the abnormal movements were muscle rippling. He also had irregular toe jerks at frequencies of 1-2 Hz with dystonic posture (in dorsiflexion), and he was able to voluntarily suppress the movements for a few seconds. Unfortunately, we performed neither electromyography (EMG) nor surface EMG recordings of the jerks. The serum CK level was mildly elevated (629 U/L, normal range 50-230 U/L), with normal levels of free T4 and TSH and negative thyroid peroxidase autoantibodies. Autoantibodies screening showed a slightly elevated AChR-Ab (0.5 nmol/L, normal <0.3 nmol/L) with negative anti-GAD, MuSK, LGI1/CASPR2, VGCC antibodies and paraneoplastic neurological antibodies (AMPH, CV2, PNMA2, Ri, Yo, Hu, recoverin, SOX1, titin, zic4, GAD65, Tr). A cerebrospinal fluid (CSF) analysis showed a slight increase in protein level (82 mg/dL, normal range 10-40 mg/dL) with a normal cell count. On a physiological examination, repetitive nerve stimulation showed no waning, and nerve conduction studies were normal. Chest computed tomography (CT) showed a mediastinal mass. Although neither signs nor symptoms of MG were observed, we suspected that the positive AChR-Ab findings suggested thymoma. He underwent extended thymectomy on the 23rd hospital day. The pathological studies of the resected specimen revealed a bronchogenic cyst with atrophic thymus tissues. Within a week after the surgery, the irregular toe jerks had disappeared. His muscle rippling gradually subsided but did not disappear. Eight months after thymectomy, we performed a muscle biopsy from the left biceps brachii muscle. Muscle pathology showed no inflammatory cell infiltration with neither necrotic nor regenerating fibers. Immunohistochemical pathology revealed mosaic patterned caveolin-3 reduction and mild inflammatory findings with major histocompatibility complex (MHC)-class I antigen positivity on non-necrotic muscle fibers (Figure). As he had no mutations in any CAV3 exons, we diagnosed him with sporadic rippling muscle disease. His muscle symptoms continuously improved the next nine months without using immunosuppressive agents. He has remained in complete symptomatic remission with slightly elevated levels of CK (273 U/L) and AChR-Ab (0.7 nmol/L) as of June, 2021 (36 months after thymectomy) without signs or symptoms of MG.
Figure.

(A) Hematoxylin and Eosin staining. Scale bars =100 μm. (B) Immunohistochemical staining with antibodies against major human histocompatibility complex class I (MHC-I). Scale bars =100 μm. (C, D) Immunohistochemical staining with an antibody against caveolin-3 (Cav3) from the patient and control. Sarcolemmal caveolin-3 immunostaining shows a moderate reduction in a mosaic pattern (C) compared to the control (D). Scale bars =100 μm.

(A) Hematoxylin and Eosin staining. Scale bars =100 μm. (B) Immunohistochemical staining with antibodies against major human histocompatibility complex class I (MHC-I). Scale bars =100 μm. (C, D) Immunohistochemical staining with an antibody against caveolin-3 (Cav3) from the patient and control. Sarcolemmal caveolin-3 immunostaining shows a moderate reduction in a mosaic pattern (C) compared to the control (D). Scale bars =100 μm.

Discussion

RMD is a rare disorder characterized by muscle stiffness and electrically silent wave-like contractions of the skeletal muscle, percussion-induced mounding and percussion-induced rapid muscle contractions (PIRCs) (1). Some cases have a genetic disorder causing RMD, while others may have an immune-mediated disorder inducing RMD (iRMD). The present patient had clinical features of RMD, no family history of RMD and no pathogenic mutations in the CAV3 gene, supporting the diagnosis of sporadic RMD. A mosaic pattern of reduced sarcolemmal caveolin-3 in the biopsied muscle is compatible with iRMD (3,10,12). Importantly, all of the muscular symptoms of our AChR-Ab-positive RMD patient had disappeared at one and a half years after extended thymectomy without intensive immunosuppressive therapies, such as steroid administration or plasmapheresis. There have been no AChR-Ab-positive RMD cases without associated cancers or MG reported in the literature. Indeed, thus far, all 21 reported cases with AChR-Ab-positive RMD were associated with MG or cancers and consistently responded to immunosuppressive treatments (2-4,6,8,10,11,13-17). However, RMD patients with neither autoimmune disorders nor cancers at the first presentation are not usually treated with intensive immunosuppressive therapies. Some of those patients develop MG with persistent rippling phenomena several months to years after the onset of RMD. Furthermore, all of the patients with AChR-Ab-positive RMD required immunosuppressive agents to achieve remission of muscle rippling (4,10,11). Although our patient had no MG symptoms, we suspected that persistently elevated levels of AChR-Ab might be a risk factor for the development of autoimmune dysfunction. We have followed up this patient for about three years after since thymectomy without recurrence of RMD or development of MG, suggesting that extended thymectomy might exert a beneficial effect on the natural course of this patient. More detailed studies will be required to establish therapies for sporadic RMD patients, especially in AChR-Ab-positive cases without obvious autoimmune diseases or cancers. Notably, our patient presented with irregular toe jerks, which have never been reported previously in patients with RMD. The jerks were irregular extensions and flexions of the toes observed at rest without apparent triggers. Although neither EMG nor surface EMG were recorded to identify the electrical properties of the jerks, we suspect that the jerks and rippling phenomena might share some common mechanisms, as both symptoms presented at the same period and might have been caused by the increased sensitivity to stretching due to the absence of caveolin-3 (18). More detailed studies are needed to clarify the mechanisms producing the jerks, which might have led to the biphasic symptomatic remissions in this case. In conclusion, we encountered a man with AChR-Ab-positive RMD who achieved complete remission one and a half years after extended thymectomy. Since symptomatic remission has not been seen in previously reported AChR-Ab-positive RMD cases without using immunosuppressive agents, we believe that these findings will prove useful for considering extended thymectomy as a therapeutic option in AChR-Ab-positive RMD patients. The authors state that they have no Conflict of Interest (COI).
  16 in total

1.  Autoimmune rippling muscle.

Authors:  Suraj Ashok Muley; John W Day
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

2.  A family with dominant hereditary myotonia, muscular hypertrophy, and increased muscular irritability, distinct from myotonia congenita thomsen.

Authors:  T Torbergsen
Journal:  Acta Neurol Scand       Date:  1975-03       Impact factor: 3.209

3.  Acquired rippling muscle disease associated with mild myasthenia gravis: a case report.

Authors:  Sander M van Schaik; V I H Kwa; A J van der Kooi
Journal:  J Neurol       Date:  2009-03-07       Impact factor: 4.849

4.  Acquired rippling muscle disease in association with myasthenia gravis.

Authors:  J S George; S Harikrishnan; I Ali; R Baresi; C O Hanemann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-01       Impact factor: 10.154

5.  Sporadic rippling muscle disease unmasked by simvastatin.

Authors:  Steven K Baker; Mark A Tarnopolsky
Journal:  Muscle Nerve       Date:  2006-10       Impact factor: 3.217

6.  Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis.

Authors:  W Müller-Felber; C F Ansevin; K Ricker; A Müller-Jenssen; M Töpfer; H H Goebel; D E Pongratz
Journal:  Neuromuscul Disord       Date:  1999-12       Impact factor: 4.296

7.  Autoimmune acquired rippling muscle disease and myasthenia gravis.

Authors:  Dane A Breker; Ann A Little; Jonathan D Trobe
Journal:  J Neuroophthalmol       Date:  2015-03       Impact factor: 3.042

8.  Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability.

Authors:  S Vernino; R G Auger; A M Emslie-Smith; C M Harper; V A Lennon
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

9.  Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two.

Authors:  Benedikt Schoser; Saiju Jacob; David Hilton-Jones; Wolfgang Müller-Felber; Christian Kubisch; Detlef Claus; Hans H Goebel; Giuseppe Vita; Angela Vincent; Antonio Toscano; Peter Van den Bergh
Journal:  Neuromuscul Disord       Date:  2009-02-08       Impact factor: 4.296

10.  Acquired rippling muscle disease with myasthenia gravis.

Authors:  Steven A Greenberg
Journal:  Muscle Nerve       Date:  2004-01       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.